The Ongoing Genetic Adaptation of Streptococcus pneumoniae
Sandra S. Richter, Daniel M. Musher
Abstract
Sandra S. Richter, Daniel M. Musher
Abstract
ABSTRACT Streptococcus pneumoniae has demonstrated a remarkable ability to adapt during the conjugate vaccine era. The increasing incidence of serotype 35B disease and emergence of a multidrug-resistant clone reported in this issue of the Journal of Clinical Microbiology (L. Olarte et al., J Clin Microbiol 55:724–734, 2017, https://doi.org/10.1128/JCM.01778-16 ) underscore the limitations of pneumococcal vaccines that target the polysaccharide capsule.
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
ABSTRACT Streptococcus pneumoniae has demonstrated a remarkable ability to adapt during the conjugate vaccine era. The increasing incidence of serotype 35B disease and emergence of a multidrug-resistant clone reported in this issue of the Journal of Clinical Microbiology (L. Olarte et al., J Clin Microbiol 55:724–734, 2017, https://doi.org/10.1128/JCM.01778-16 ) underscore the limitations of pneumococcal vaccines that target the polysaccharide capsule.
Key concepts: Streptococcus pneumoniae, Adaptation (eye), Microbiology, Biology, Antibiotics, Neuroscience